BilliontoOne Northstar Select and Northstar Response

Liquid biopsy tests that track biomarkers in blood to guide treatment and monitor disease progression.

Vetted listing

Testing

Consented intake · your records travel with you · nothing moves without your sign-off

Why BilliontoOne exists

BilliontoOne's Northstar Select and Northstar Response are liquid biopsy tests that gather and analyze bodily fluids for biomarkers including DNA, RNA, and proteins. They support treatment guidance, minimum residual disease monitoring, and early detection. For patients, these tests offer a way to follow the disease over the course of care.

Typically within 10 days from sample receipt to resultsCLIA · 05D2275351Pennsylvania license · 40795Part of BillionToOne

Prefer the source? BilliontoOne Northstar Select and Northstar Response's own site has more.

Share your records

We'll pre-fill the intake from your records — no retyping.

Start sharing →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how BilliontoOne Northstar Select and Northstar Response handles billing.

We don't have confirmed insurance details for BilliontoOne Northstar Select and Northstar Response yet. Start a coverage check with your plan, or contact the provider directly.

Common questions about BilliontoOne

How long does BilliontoOne take?

Typically within 10 days from sample receipt to results

How do I connect with BilliontoOne?

Through OpenCancer's consented intake: enter your details once, choose exactly which records travel with the request, and sign a consent that covers this connection only. Nothing is shared without your sign-off.

Ask about this service

Answers grounded in BilliontoOne's details here. Educational only; your oncologist directs treatment.

Also consider

Other providers in similar categories.

BostonGene

6 offerings

Gather distinctive biomarkers that can guide treatment and monitor disease progression

Foundation Medicine

6 offerings

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.